Inhibiting Endothelial SMS2 Alleviates Atherosclerosis by Blocking Endothelial‑Mesenchymal Transition Through Boosted Fatty Acid Oxidation
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-06 · 46 (6)
DOI: 10.1161/atvbaha.126.324346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-06. Verfasst von Ximian Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Affiliated Hospital of Nanchang University, and Department of Biochemistry and Molecular Biology, School of Basic Me…. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, Atherosclerosis, Fatty Acids, Human Umbilical Vein Endothelial Cells. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Endothelial-to-mesenchymal transition (EndMT) is implicated in atherosclerosis by contributing to endothelial dysfunction (ED). SMS2 (sphingomyelin synthase 2), a key enzyme in sphingomyelin synthesis, plays a significant role in both ED and atherosclerosis. Nonetheless, the precise mechanisms of SMS2-associated ED, and its potential modulation via EndMT remain unexplored in the context of ED and atherosclerosis progression. METHODS: To investigate this, we inhibited SMS2 activity using the inhibitor Ly93 and performed RNA sequencing on human umbilical vein endothelial cells. Furthermore, we validated the potential mechanisms of EndMT in human umbilical vein endothelial cells, Apo E −/− mice, and human atherosclerotic plaques. RESULTS: SMS2 inhibition suppressed EndMT by blocking the Wnt/β-catenin pathway. This blockade attenuated PPARγ (peroxisome proliferator-activated receptor gamma) ubiquitination-mediated degradation via PPARγ-β-catenin interaction, ultimately reducing CPT1A expression and fatty acid oxidation. In vivo, endothelial cell-specific overexpression of SMS2 in ApoE −/− mice enhances atherosclerosis, and SMS2 positively correlates with Wnt/β-catenin, EndMT, and ED, but inversely correlates with PPARγ activity and fatty acid oxidation. Furthermore, in the unstable atherosclerosis plaques of humans, the expression of SMS2 in endothelial cells is significantly higher compared with that in stable plaques. The relationship between SMS2 and Wnt/β-catenin, EndMT, ED, PPARγ, and fatty acid oxidation aligns with the aforementioned findings. CONCLUSIONS: SMS2 can activate the Wnt/β-catenin pathway, which is inversely correlated with the activity of PPARγ and fatty acid oxidation. This process facilitates EndMT and ED, ultimately contributing to the initiation and development of atherosclerosis. These findings suggest that inhibition of endothelial SMS2 activity with Ly93 could be beneficial for the treatment of atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Second Affiliated Hospital of Nanchang University, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang…
- Department of Vascular Surgery (T.Z.), the Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Department of Cardiology (R.Y.), the Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Department of Hematology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi Provincial Key Laboratory of Hematological Diseases (2024SSY06052; L.Y.).
ORCID-Profile: Teng Zhang, Xiaojuan Hu, Renqiang Yang, Li Yu, Nianlong Yan
Zitieren
APA
Zheng, X., Ye, H., Zhang, T., Hu, X., Yang, R., Yu, L., & Yan, N. (2026). Inhibiting Endothelial SMS2 Alleviates Atherosclerosis by Blocking Endothelial‑Mesenchymal Transition Through Boosted Fatty Acid Oxidation. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(6). https://doi.org/10.1161/atvbaha.126.324346
Vancouver
Zheng X, Ye H, Zhang T, Hu X, Yang R, Yu L, et al. Inhibiting Endothelial SMS2 Alleviates Atherosclerosis by Blocking Endothelial‑Mesenchymal Transition Through Boosted Fatty Acid Oxidation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(6). doi:10.1161/atvbaha.126.324346
BibTeX
@article{Zheng2026,
author = {Zheng, Ximian and Ye, Hua and Zhang, Teng and Hu, Xiaojuan and Yang, Renqiang and Yu, Li and Yan, Nianlong},
title = {Inhibiting Endothelial SMS2 Alleviates Atherosclerosis by Blocking Endothelial‑Mesenchymal Transition Through Boosted Fatty Acid Oxidation},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
volume = {46},
number = {6},
doi = {10.1161/atvbaha.126.324346}
}
EUVIMED